Journal article
Minimum active structure of insulin-like peptide 5
A Belgi, RAD Bathgate, M Kocan, N Patil, S Zhang, GW Tregear, JD Wade, MA Hossain
Journal of Medicinal Chemistry | AMER CHEMICAL SOC | Published : 2013
DOI: 10.1021/jm400924p
Abstract
Insulin-like peptide 5 (INSL5) is a complex two-chain peptide hormone constrained by three disulfide bonds in a pattern identical to insulin. High expression of INSL5 in the colon suggests roles in activation of colon motility and appetite control. A more recent study indicates it may have significant roles in the regulation of insulin secretion and β-cell homeostasis. This peptide thus has considerable potential for the treatment of eating disorders, obesity, and/or diabetes. However, the synthesis of INSL5 is extremely challenging either by chemical or recombinant means. The A-chain is very poorly soluble and the B-chain is highly aggregating in nature which, together, makes their postsynt..
View full abstractRelated Projects (3)
Grants
Awarded by NHMRC (Australia)
Awarded by ARC
Awarded by Australian Research Council
Funding Acknowledgements
This research was partly funded by NHMRC (Australia) project grants (508995, 1023078, 1023321) and ARC linkage grant (LP120100654) to J.D.W., M.A.H., R.A.D.B., and R.A.H. We are grateful to Tania Ferraro and Sharon Layfield for assistance with biochemical assays and to Feng Lin for amino acid analysis. During these studies, M.A.H. was the recipient of Florey Foundation Fellowships. R.A.D.B. is an NHMRC Senior Research Fellow, and J.D.W. is an NHMRC Principal Research Fellow. Studies at the FINMH were supported by the Victorian Government's Operational Infrastructure Support Program.